Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats

Zapnometinib is a MEK inhibitor currently under clinical development for the treatment of COVID-19 and influenza. Zapnometinib has both antiviral and immunomodulatory effects. Information concerning the absorption, distribution, metabolism, and excretion of the compound following single oral doses o...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yvonne Füll, Christian Wallasch, Ashley Hilton, Oliver Planz
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2022-12-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	mek inhibitor absorption distribution metabolism excretion antiviral therapy
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1050193/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!